- News & Features
International rheumatology, dermatology, neurology, and pediatric groups have endorsed the new criteria.
The introduction of biologic disease-modifying anti-rheumatic drugs are associated with a decrease in total knee replacements among RA patients.
These findings suggest that there is a window of opportunity to treat patients with undifferentiated arthritis early, to delay subsequent progression to RA.
CJ blogger, The Unexpected Advocate, writes about a tough issue.
Rheumatoid arthritis patients who take opioids or antidepressants are likelier to fracture their bones, according to research presented at the 2017 American College of Rheumatology annual meeting in San Diego.
Rheumatoid arthritis patients who are overweight are at elevated risk of synovitis, an inflammation of the joint lining, according to...
Treat-to-target, evidence-based guidelines recommend that rheumatoid arthritis patients be monitored regularly for disease activity and that therapy is adjusted —...
Arthritis patients with resolved hepatitis B infection, who received disease-modifying antirheumatic drugs (DMARDs) such as methotrexate, were unlikely to have the hepatitis B resurface.
Rheumatoid arthritis and osteoarthritis patients have received suboptimal screenings and treatment for osteoporosis despite having a higher risk for that disease.
Men who work in bricklaying, concrete, material handling, and electronics, and women who are nursing assistants and attendants may be at higher risk for rheumatoid arthritis, per a recent study in Arthritis Care & Research.